Kidron Miriam 4
4 · ORAMED PHARMACEUTICALS INC. · Filed Jan 6, 2025
Insider Transaction Report
Form 4
Kidron Miriam
DirectorChief Scientific Officer
Transactions
- Award
Common Stock
2025-01-02+207,000→ 1,000,666 total
Footnotes (1)
- [F1]Represents Restricted Stock Units ("RSUs") that will vest in quarterly installments of approximately 17,250 over a three year period starting January 1, 2025. The RSUs convert into the Issuer's Common Stock on a one-for-one basis.